Cargando…

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?

Detalles Bibliográficos
Autor principal:	Monteiro, Olivia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874488/ https://www.ncbi.nlm.nih.gov/pubmed/37521852 http://dx.doi.org/10.1002/mef2.20

Ejemplares similares

SARS-CoV-2 vaccines: anamnestic response in previously infected recipients
por: Purushotham, Jyothi N., et al.
Publicado: (2021)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection
por: Li, Zhe, et al.
Publicado: (2023)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

A two‐step infection model: From SARS‐CoV‐2 entry and trafficking to egress and spread
por: You, Liting, et al.
Publicado: (2023)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

Explorative probes and biomarkers, chronic Salmonella infections and future vaccines
por: Michán, Carmen, et al.
Publicado: (2012)

Cellular basis for SARS-CoV-2 infection
por: Baumann, Kim
Publicado: (2020)

SARS-CoV-2 variant Omicron: currently the most complete “escapee” from neutralization by antibodies and vaccines
por: Li, Maochen, et al.
Publicado: (2022)

Level up for culture models - How 3D cell culture models benefit SARS-CoV-2 research
por: Häfner, Sophia Julia
Publicado: (2021)

Organoids demonstrate gut infection by SARS-CoV-2
por: Dickson, Iain
Publicado: (2020)

Effects of pancreatic SARS-CoV-2 infection identified
por: Morris, Alan
Publicado: (2021)

The SARS-CoV-2 spike protein: balancing stability and infectivity
por: Berger, Imre, et al.
Publicado: (2020)

Profiling and characterization of SARS-CoV-2 mutants’ infectivity and antigenicity
por: Wang, Lin, et al.
Publicado: (2020)

AngII autoantibodies after SARS-CoV-2 infection
por: Wang, Monica
Publicado: (2022)

ZBP1 inflames the SARS-CoV-2-infected lung
por: Yin, Chaoran, et al.
Publicado: (2023)

Double insult: flu bug enhances SARS-CoV-2 infectivity
por: Su, Shan, et al.
Publicado: (2021)

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes
por: Brewer, R. Camille, et al.
Publicado: (2022)

A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus
por: Wang, Junzhi
Publicado: (2021)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
por: Noh, Ji Yun, et al.
Publicado: (2021)

A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Virtual Issue on SARS-CoV-2: Evolution of a Pandemic
por: McGrath, Casey
Publicado: (2023)

SARS-CoV-2 spike protein: flexibility as a new target for fighting infection
por: Pierri, Ciro Leonardo
Publicado: (2020)

SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
por: Allison, Susan J.
Publicado: (2020)

SARS-CoV-2 infection and the brain: direct evidence for brain changes in milder cases
por: Sollmann, Nico, et al.
Publicado: (2022)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
por: Wan, Cheng, et al.
Publicado: (2021)

Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium
por: Su, Peng, et al.
Publicado: (2023)

Omicron variant: a booster depending on infection histories
por: Wang, Jiayu, et al.
Publicado: (2023)

SARS-CoV-2 Variants of Concern Delta: a great challenge to prevention and control of COVID-19
por: Li, Maochen, et al.
Publicado: (2021)

Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants
por: Pawelec, Graham, et al.
Publicado: (2021)

Structural insights into the Omicron spike trimer: tackling the challenges of continuously evolving SARS-CoV-2 variants
por: Ou, Junxian, et al.
Publicado: (2022)

Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022)

A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues
por: Min, Long, et al.
Publicado: (2022)

The inflammasome: Friend or foe in Chlamydia infection?
por: Walton, Emma Louise
Publicado: (2016)

Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua
por: Maier, Hannah E., et al.
Publicado: (2022)

SARS-CoV-2 variants: a new challenge to convalescent serum and mRNA vaccine neutralization efficiency
por: Li, Maochen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a9ge7e1nikre1vlh7jat7qg17i